BodySpec has opened a new storefront in Oakland offering low‑cost dual‑energy X‑ray absorptiometry (DEXA) scans aimed at tracking muscle loss associated with GLP‑1 weight‑loss medications. The 12‑minute procedure costs under $60 and provides detailed body composition data that scales cannot deliver.
The clinic’s co‑founder and chief executive, Elaine Shi, explains that the service fills a gap left by traditional scales, which only report weight changes without distinguishing fat, muscle, or other tissues. „Patients on GLP‑1 drugs often lose lean mass along with fat, and that can affect health outcomes,” Shi says. The scans give clinicians and patients a clearer picture of how treatment is impacting body composition.
GLP‑1 agonists, such as semaglutide, have become mainstream for weight management. While they are effective at reducing body fat, studies show they can also cause significant muscle loss. This loss of lean tissue can compromise metabolic health, mobility, and overall well‑being. BodySpec’s scans aim to monitor these changes, allowing physicians to adjust therapy or recommend strength‑training interventions.
The service is priced at $59.99, making it one of the most affordable DEXA options in the region. Each scan takes roughly 12 minutes, after which patients receive a comprehensive report detailing bone density, fat mass, and lean mass by region. The data can be shared with healthcare providers to inform personalized treatment plans.
DEXA machines use two low‑dose X‑ray beams to differentiate between bone, fat, and lean tissue. The technology is highly accurate, with a margin of error of less than 1 %. Patients sit on a scanner bed while the machine rotates around them, capturing images that are then analyzed by software. The resulting report is delivered digitally within minutes of the scan.
The primary beneficiaries are patients on GLP‑1 therapy, but the service also appeals to athletes, older adults, and anyone interested in precise body composition tracking. By identifying muscle loss early, patients can take corrective action—such as resistance training or nutritional adjustments—before significant functional decline occurs.
The introduction of affordable DEXA scans could shift how clinicians monitor weight‑loss regimens. Currently, most doctors rely on weight and body mass index (BMI) alone, which overlook changes in muscle mass. With more accessible technology, providers may be able to tailor treatments more effectively, potentially improving long‑term outcomes for patients on GLP‑1 drugs.
The Oakland clinic is part of a growing trend toward precision health services that combine advanced imaging with actionable data. If the model proves successful, similar storefronts could appear in other cities, expanding access to body composition analysis for a broader population.
What is the difference between a DEXA scan and a regular body scan? A DEXA scan uses dual‑energy X‑ray beams to separate bone, fat, and lean tissue, providing precise measurements of each component. A regular scan typically measures only overall weight or surface metrics.
Will insurance cover the cost of a DEXA scan for GLP‑1 patients? Coverage varies by insurer. Some plans may reimburse the scan if it is deemed medically necessary for monitoring therapy side effects, but patients should check with their provider.
How often should someone on GLP‑1 medication get a DEXA scan? The recommended frequency depends on individual goals and health status. Many clinicians suggest an initial scan at baseline, followed by periodic scans every 3–6 months to track changes.